McDermott Will & Emery: Precision Health: Perspectives on Precision Partnering
BackJun 29, 2021 9:30 am - 10:30 am PT
Precision medicine has, and will continue to, dramatically transform the healthcare landscape by developing and implementing cutting-edge solutions that significantly improve patient outcomes. Through the groundbreaking creation and rapid development of diagnostic tools and treatments for cancer and other conditions, effective partnerships and collaborations have become essential to advancing this new era of patient care and disease prevention.
Our panel of healthcare leaders from prominent organizations at the forefront of precision health initiatives will share their perspectives on key topics and evolving trends, including:
• Precision health: What it is, how organizations define it and the factors driving its growth
• Approaches to incorporating precision medicine in digital health and virtual care, including operational, legal and ethical considerations regarding virtual care, genetic consulting, blockchain, artificial intelligence (AI) and more
• Challenges facing precision medicine initiatives across the ecosystem of healthcare and life sciences, including relevant legal and regulatory regimes
• Insights on the industry’s future direction and potential developments that may impact the field
• The investor’s view: Exploring co-arrangements, acquisition strategies and payment/reimbursement across the supply chain
Moderator: Carolyn V. Metnick, Partner, McDermott Will & Emery
Panelists:
• Leonard Achan, Chief Innovation Officer; Senior Vice President, Hospital for Special Surgery
• Michael Hamilton, Chief Privacy Officer, Invitae
• Anushka Sunder, Managing Director, Blackstone
• Ingrid Vasiliu-Feltes, M.D., President, Detect Genomix | Chief Quality & Innovation Officer, MEDNAX